The guidelines say that it is "reasonable to offer" statin treatment to a middle-age person with a 7.5% or greater 10-year risk for a ASCVD event and no other risks that warrant statin treatment and that before starting statin treatment, it is "reasonable" for a physician and patient to have a discussion that covers the patient’s individual risk level, the potential risks and benefits of statin treatment, and patient preference.
Aside from their critique of the risk calculator, Dr. Ridker and Dr. Cook applauded the overall guidelines in their commentary, calling them "a major step in the right direction."
On Twitter @mitchelzoler